Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Rapt Therapeutics Inc RAPT

Healthcare Biotechnology
RAPT Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company. The Company is focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology. Utilizing its drug discovery and development engine, it develops selective small molecules designed to modulate the critical... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:RAPT)

RAPT Therapeutics Reports Third Quarter 2024 Financial Results

GlobeNewswire 12 days ago

Based on Recent FDA Feedback RAPT Therapeutics Stops Zelnecirnon Program Following Clinical Hold Due to Single SAE of Severe Liver Injury

GlobeNewswire 13 days ago

RAPT Therapeutics Reports Second Quarter 2024 Financial Results

GlobeNewswire August 8, 2024

RAPT Therapeutics Reports First Quarter 2024 Financial Results

GlobeNewswire May 9, 2024

RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients

GlobeNewswire April 9, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutics, Inc. - RAPT

PR Newswire March 11, 2024

RAPT Investigation: Kessler Topaz Meltzer & Check, LLP is Investigating Potential Securities Fraud Claims on Behalf of Investors of RAPT Therapeutics, Inc. (RAPT)

Newsfile March 11, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutics, Inc. - RAPT

Accesswire March 9, 2024

RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire March 7, 2024
View More News ››

Opinion & Analysis (NDAQ:RAPT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:RAPT)

Overweight Recommendation Issued On RAPT By Wells Fargo

Breaking News: $RAPT Overweight Recommendation Issued On RAPT By Wells Fargo2024-08-12 00:00:07 ET Wells Fargo analyst issues OVERWEIGHT...
whytestocks - August 12, 2024

RAPT Therapeutics Faces Challenges Amid Clinical Holds and W

http://beyondspx.com/2024/08/01/rapt-therapeutics-faces-challenges-amid-clinical-holds-and-workforce-reduction/
MikeTester - August 2, 2024

Why Is Inflammatory Disease/Oncology-Focused RAPT Therapeuti

News; $RAPT Why Is Inflammatory Disease/Oncology-Focused RAPT Therapeutics Shares Tumbling Today? | BenzingaTuesday, the FDA verbally...
whytestocks - February 20, 2024

4 BIOTECH STOCKS INSIDERS ARE SELLING!

$RAPT $DCPH $FGEN $SGTX  Insider selling cannot be the sole indicator for investing in a stock, but it would be wise...
AviseAnalytics - October 12, 2021

$iMIN making moves in Ethereum Crypto !! 🚀🚀🚀🚀🚀

iMining Launches Fractional Staking to Enable Retail Investors to Participate in Ethereum 2.0's Proof-Of-Stake Mining Vancouver...
Saaaa1 - May 6, 2021

RE:This looks like it is going to rip

Made money here last month.   Price is right here for me.  Took a position again today.
mevani - December 29, 2020
View more Bullboard ››

Forge Resources Corp.

Forge Resources Corp.

Forge Resources Corp. is a junior exploration company. The Company is engaged in the business of the exploration and ...
View More »